Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | TERT | O14746 | 3/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 3/20 | 0.68 |
| ▸ | PPARD | Q03181 | 3/20 | 0.68 |
| ▸ | PPARA | Q07869 | 3/20 | 0.68 |
| ▸ | FAAH | O00519 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15500041 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL3228812 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL3123425 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL1114787 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL22230778 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL5478764 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL7243894 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL6713314 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL22230779 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL11060705 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122012182-A | Method for synthesizing branched fatty acid ester of hydroxy fatty acid by taking natural oil containing hydroxy fatty acid as raw material | 江南大学 | 2026-05-12 | — | — | CN | claimed |
| WO-2015134256-A1 | COMBINATORIAL LIBRARIES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-11 | — | — | WO | claimed |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260007741-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINES | AKAGERA MEDICINES, INC. (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250387462-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINE FOR THE PREVENTION OF TUBERCULOSIS OR OTHER MYCOBACTERIAL INFECTIONS | AKAGERA MEDICINES, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| EP-3695850-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A NEGATIVELY CHARGED DRUG AND A CATIONIC LIPID | SAMYANG HOLDINGS CORP (KR) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025034764-A1 | LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Life Technologies Corporation (US) | 2025-02-13 | — | — | WO | disclosed |
| CN-118388709-B | Preparation method of functional auxiliary agent for composite packaging adhesive film for main-grid-free battery assembly | 苏州易昇光学材料股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| US-20240325525-A1 | Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof | AKAGERA MEDICINES, INC. (US) | 2024-10-03 | — | — | US | disclosed |
| US-12064479-B2 | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | AKAGERA MEDICINES, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-7319157-B1 | Creatine-fatty acids | MULTI FORMULATIONS LTD. (CA) | 2008-01-15 | — | — | US | disclosed |
| EP-1691814-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-08-23 | — | — | EP | disclosed |
| EP-1252135-B1 | ESTERS OF FATTY ACIDS AND JUVENOID ALCOHOLS, AND A METHOD OF THEIR PREPARATION AND USE | ACAD OF SCIENCE CZECH REPUBLIC (CZ) | 2005-11-16 | — | — | EP | disclosed |
| WO-2005053702-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2005-06-16 | — | — | WO | disclosed |
| US-6734316-B2 | SUCH AS ETHYL-N-(2-(4-((CIS-2-OCTADECANOYLOXYCYCLOHEXYL) METHYL)PHEYNOXY)ETHYL)CARBAMATE FOR INSECT POPULATION DENSITY CONTROL | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR (CZ) | 2004-05-11 | — | — | US | disclosed |
| US-6548486-B1 | New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid | NORSK HYDRO A.S. (NO) | 2003-04-15 | — | — | US | disclosed |
| US-20030028047-A1 | Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR (CZ) | 2003-02-06 | — | — | US | disclosed |
| WO-1993007163-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO A.S. (NO) | 1993-04-15 | — | — | WO | disclosed |
| EP-0350672-A1 | Salts of diacyl-glycero-(di)-phosphates of L-(acyl) carnitine and of L-acyl-carnitine esters | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, PLTP, SGMS1 | ALDH1A1 4716/4885TSHR 4047/4885TERT 4172/4885 |
| US-20250387462-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINE FOR THE PREVENTION OF TUBERCULOSIS OR OTHER MYCOBACTERIAL INFECTIONS | CD4, MICA, LNPK | ALDH1A1 4826/4885TSHR 2942/4885TERT 2630/4885 |
| US-20030028047-A1 | Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use | ALOX15, LIPC, CPT1A | ALDH1A1 1603/4885TSHR 2373/4885TERT 247/4885 |
| US-20260007741-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINES | TLR9, TLR3, TLR8 | ALDH1A1 4581/4885TSHR 3557/4885TERT 3240/4885 |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, LNPK, SGMS2 | ALDH1A1 4782/4885TSHR 3848/4885TERT 4009/4885 |
| US-12064479-B2 | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | PHOSPHO1, PTDSS1, PTDSS2 | ALDH1A1 4475/4885TSHR 4168/4885TERT 3704/4885 |
| US-20240325525-A1 | Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof | PHOSPHO1, PTDSS1, PTDSS2 | ALDH1A1 4475/4885TSHR 4168/4885TERT 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.